United States Department of Housing and Urban Development. The 2015 annual homeless assessment report (AHAR) to congress. 2015.
Google Scholar
Centers for Disease Control and Prevention. TB in the Homeless Population. [http://www.cdc.gov/tb/topic/populations/homelessness/default.htm]. Accessed 16 Sep 2016.
Bamrah S, Yelk Woodruff RS, Powell K, Ghosh S, Kammerer JS, Haddad MB. Tuberculosis among the homeless, United States, 1994-2010. Int J Tuberc Lung Dis. 2013;17:1414–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2015. 2016.
Google Scholar
Kushel MB, Vittinghoff E, Haas JS. Factors associated with the health care utilization of homeless persons. JAMA. 2001;285:200–6.
Article
CAS
PubMed
Google Scholar
Wojtusik L, White MC. Health status, needs, and health care barriers among the homeless. J Health Care Poor Underserved. 1998;9:140–52.
Article
CAS
PubMed
Google Scholar
Higgins J, Green S. Cochrane handbook for systematic reviews of interventions, 5.1.0: The Cochran Collaboration; 2011. http://handbook-5-1.cochrane.org/.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Article
PubMed
PubMed Central
Google Scholar
PROSPERO: Inernational Prospective Registry of Systematic Reviews. [https://www.crd.york.ac.uk/PROSPERO/]. Accessed 20 May 2016.
Beijer U, Wolf A, Fazel S. Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:859–70.
Article
PubMed
PubMed Central
Google Scholar
Alexander S. Engaging community stakeholders to control a homeless shelter outbreak in Indiana. TB Notes. 2011:7–10.
Lashley M. A targeted testing program for tuberculosis control and prevention among Baltimore City's homeless population. Public Health Nurs. 2007;24:34–9.
Article
PubMed
Google Scholar
Cheung RC, Hanson AK, Maganti K, Keeffe EB, Matsui SM. Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol. 2002;34:476–80.
Article
PubMed
Google Scholar
Saez H, Valencia E, Conover S, Susser E. Tuberculosis and HIV among mentally ill men in a new York City shelter. Am J Public Health. 1996;86:1318–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barry MA, Wall C, Shirley L. Tuberculosis screening in Boston's homeless shelters. Public Health Rep. 1986;101:487–94.
CAS
PubMed
PubMed Central
Google Scholar
Gelberg L, Panarites CJ, Morgenstern H, Leake B, Andersen RM, Koegel P. Tuberculosis skin testing among homeless adults. J Gen Intern Med. 1997;12:25–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Paul EA, Lebowitz SM, Moore RE, Hoven CW, Bennett BA, Chen A. Nemesis revisited: tuberculosis infection in a new York City men's shelter. Am J Public Health. 1993;83:1743–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sakai J, Kim M, Shore J, Hepfer M. The risk of purified protein derivative positivity in homeless men with psychotic symptoms. South Med J. 1998;91:345–8.
Article
CAS
PubMed
Google Scholar
Neims SR, Fantry LE, Lee EU. Tuberculin positivity among the homeless. J Health Care Poor Underserved. 1992;3:263–9.
Article
CAS
PubMed
Google Scholar
Forman PD, Kinney C. Evaluation of a tuberculosis screening questionnaire for use in an Alaskan homeless population. Alaska Med. 2003;45:94–101.
PubMed
Google Scholar
McAdam JM, Brickner PW, Scharer LL, Crocco JA, Duff AE. The spectrum of tuberculosis in a new York City men's shelter clinic (1982-1988). Chest. 1990;97:798–805.
Article
CAS
PubMed
Google Scholar
Morrow R, Fanta J, Kerlen S. Tuberculosis screening and anergy in a homeless population. J Am Board Fam Pract. 1997;10:1–5.
CAS
PubMed
Google Scholar
Griffin RG, Hoff GL. Tuberculosis screening in Kansas City homeless shelters. Mo Med. 1999;96:496–9.
CAS
PubMed
Google Scholar
Torres RA, Mani S, Altholz J, Brickner PW. Human immunodeficiency virus infection among homeless men in a new York City shelter. Association with Mycobacterium tuberculosis infection. Arch Intern Med. 1990;150:2030–6.
Article
CAS
PubMed
Google Scholar
Nolan CM, Elarth AM, Barr H, Saeed AM, Risser DR. An outbreak of tuberculosis in a shelter for homeless men. A description of its evolution and control. Am Rev Respir Dis. 1991;143:257–61.
Article
CAS
PubMed
Google Scholar
Valencia E, Saez H. Assessment of TB screening inclusion in time-limited case management for hard-to-reach severe mentally ill individuals at risk for HIV: TB screening and critical time intervention (CTI) in new York City. XV International Aids Conference: Social and Economical Issues; 2004. p. 343–7.
Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis. 2006;6:47.
Article
PubMed
PubMed Central
Google Scholar
Higashi J. Programmatic experience with IGRA testing: San Francisco. Boston, MA: North America Regional IUATLD Conference; 2014.
Google Scholar
McAdam JM, Bucher SJ, Brickner PW, Vincent RL, Lascher S. Latent tuberculosis and active tuberculosis disease rates among the homeless, New York, New York, USA, 1992-2006. Emerg Infect Dis. 2009;15:1109–11.
Article
PubMed
PubMed Central
Google Scholar
Bock NN, Metzger BS, Tapia JR, Blumberg HM. A tuberculin screening and isoniazid preventive therapy program in an inner-city population. Am J Respir Crit Care Med. 1999;159:295–300.
Article
CAS
PubMed
Google Scholar
Kimerling ME, Shakes CF, Carlisle R, Lok KH, Benjamin WH, Dunlap NE. Spot sputum screening: evaluation of an intervention in two homeless shelters. Int J Tuberc Lung Dis. 1999;3:613–9.
CAS
PubMed
Google Scholar
Falchook G, Gaffga C, Eve S, Ali J. Tuberculosis screening, referral, and treatment in an inner city homeless shelter in Orleans parish. J Louisiana State Med Soc. 2000;152:398–404.
CAS
Google Scholar
Kong PM, Tapy J, Calixto P, Burman WJ, Reves RR, Yang Z, Cave MD. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis. 2002;8:1280–4.
Article
PubMed
PubMed Central
Google Scholar
Centers for Disease Control. Prevention and control of tuberculosis in U.S. communities with at-risk minority populations. Recommendations of the advisory Council for the Elimination of tuberculosis. MMWR Recommend Reports. 1992;41:1–11.
Google Scholar
Miramontes R, Hill AN, Yelk Woodruff RS, Lambert LA, Navin TR, Castro KG, LoBue PA. Tuberculosis infection in the United States: prevalence estimates from the National Health and nutrition examination survey, 2011-2012. PLoS One. 2015;10:e0140881.
Article
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2011;60:1650–3.
Google Scholar
Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365:2155–66.
Article
CAS
PubMed
Google Scholar
Moro RN, Sterling TR, Saukkonen J, Vernon A, Horsburgh CR, Chaisson RE, Hamilton CD, Villarino ME, Goldberg S. Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial. Int J Tuberc Lung Dis. 2017;21:286–96.
Article
CAS
PubMed
Google Scholar
Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:1269–78.
Article
PubMed
Google Scholar
Sandul AL, Nwana N, Holcombe JM, Lobato MN, Marks S, Webb R, Wang SH, Stewart B, Griffin P, Hunt G, et al. High rate of treatment completion in program settings with 12-dose weekly isoniazid and rifapentine (3HP) for latent Mycobacterium tuberculosis infection. Clin Infect Dis. 2017; https://doi.org/10.1093/cid/cix505.
Centers for Disease Control and Prevention. Online Tuberculosis Information System (OTIS) Data. [https://wonder.cdc.gov/tb.html]. Accessed 3 Nov 2017.
Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:e1–e33.
Article
PubMed
Google Scholar
U. S. Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Bauman L, Davidson KW, Epling JW Jr, Garcia FA, Herzstein J, Kemper AR, et al. Screening for latent tuberculosis infection in adults: US preventive services task force recommendation statement. JAMA. 2016;316:962–9.
Article
Google Scholar
Khan K, Wang J, Hu W, Bierman A, Li Y, Gardam M. Tuberculosis infection in the United States: national trends over three decades. Am J Respir Crit Care Med. 2008;177:455–60.
Article
PubMed
Google Scholar